Arundhati Parmar

A family vacation with 25 relatives was interrupted by a trip to an ER in Rome.

In this latest episode, Arundhati explores how one Mayo Clinic doctor found purpose in her deeply personal tragedy and how Mayo Clinic Florida then took her idea, executed on it and is attempting to scale it.

In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.

Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of cancer patients.

Earlier this month Sachin Jain, CEO of SCAN Health Plan, a nonprofit Medicare Advantage company, provided some refreshing straight talk on what is wrong with MA while stressing that it is far better than traditional Medicare for seniors.

All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA tackling data encryption. Bryan Marlatt, chief regional officer at CyXcel, talks with us about the evolving threat landscape and what the proposed rule means for healthcare organizations.

Many experts — be they venture capitalists or private equity investors — shared their advice with biotech entrepreneurs navigating a tough funding environment.

A conversation with David Bardan, the general manager of the healthcare business at Clear, shows how the company is bringing its expertise to counter cybersecurity threats in the healthcare industry.

The serial entrepreneur and CEO of Transcarent has dismissed care navigation companies in the past. What led him to buy Accolade, the biggest — though struggling — name in navigation?

Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley.

The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question?

Joseph DeVivo, CEO of portable ultrasound device firm Butterfly Network, led the company's return to revenue growth in 2024. Now, he wants to have the device be firmly entrenched in hospitals.

Albert Bourla and other healthcare CEOs talked about the efficacy of vaccines and how public health could take a big turn for the worse if the incoming Trump administration veered away from accepted norms regarding vaccines.

In a sit-down interview at the annual J.P. Morgan Healthcare conference, Allen talked about a tool built by a company backed by General Catalyst and Andreessen Horowitz.

More than a decade ago, Medtronic announced that a pivotal trial testing its renal denervation system had failed. Though the system was later approved by the FDA, reimbursement has been elusive. All that might change this year.

Dr. Shantanu Nundy describes how care navigation company Accolade can help self-insured employers lower costs for providing health coverage to their employees.

Swiss Medtech Company Medacta teamed up with Geisinger to begin providing the world's first, lifetime guarantee on shoulder replacement surgeries.

In an interview, Rabah talked about the promise of AI, where it can have the most impact, while also responding to the IRA and high drug prices in the United States.

How are employers tackling the current landscape of healthcare costs? We turned to Shawn Gremminger, CEO of the National Alliance of Healthcare Purchaser Coalitions, a group of regional coalitions representing self-insured employers large and small that cover roughly 40 million people.

Two chief information security officers offer some advice at a cybersecurity panel at HLTH.